713 related articles for article (PubMed ID: 9361306)
1. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
Nakai A; Kuroda S; Kristián T; Siesjö BK
Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
[TBL] [Abstract][Full Text] [Related]
2. Delayed treatment with alpha-phenyl-N-tert-butyl nitrone (PBN) attenuates secondary mitochondrial dysfunction after transient focal cerebral ischemia in the rat.
Kuroda S; Katsura K; Hillered L; Bates TE; Siesjö BK
Neurobiol Dis; 1996 Apr; 3(2):149-57. PubMed ID: 9173922
[TBL] [Abstract][Full Text] [Related]
3. Maternal treatment with alpha-phenyl-N-tert-butylnitrone attenuates secondary mitochondrial dysfunction after transient intrauterine asphyxia in the fetal rat brain.
Taniuchi Y; Nakai A; Koshino T; Araki T
Gynecol Obstet Invest; 2003; 55(3):145-50. PubMed ID: 12865593
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
5. Activity of mitochondrial respiratory chain enzymes after transient focal ischemia in the rat.
Canevari L; Kuroda S; Bates TE; Clark JB; Siesjö BK
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1166-9. PubMed ID: 9390648
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia.
Li PA; Kristián T; He QP; Siesjö BK
Exp Neurol; 2000 Sep; 165(1):153-63. PubMed ID: 10964494
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of secondary brain injury.
Siesjö BK; Siesjö P
Eur J Anaesthesiol; 1996 May; 13(3):247-68. PubMed ID: 8737117
[TBL] [Abstract][Full Text] [Related]
8. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats.
Nito C; Kamiya T; Ueda M; Arii T; Katayama Y
Brain Res; 2004 May; 1008(2):179-85. PubMed ID: 15145754
[TBL] [Abstract][Full Text] [Related]
9. Regional cerebral blood flow during and after 2 hours of middle cerebral artery occlusion in the rat.
Tsuchidate R; He QP; Smith ML; Siesjö BK
J Cereb Blood Flow Metab; 1997 Oct; 17(10):1066-73. PubMed ID: 9346431
[TBL] [Abstract][Full Text] [Related]
10. Maternal treatment with NMDA receptor antagonist (MK-801) attenuates delayed mitochondrial dysfunction after transient intrauterine ischemia in the neonatal rat brain.
Nakai A; Shibazaki Y; Taniuchi Y; Koshino T; Yokoyama K
J Anesth; 2001; 15(4):217-22. PubMed ID: 14569439
[TBL] [Abstract][Full Text] [Related]
11. Developmental changes in tolerance to transient intrauterine ischemia in rat cerebral mitochondria.
Nakai A; Taniuchi Y; Asakura H; Oya A; Yokota A; Koshino T; Araki T
Am J Obstet Gynecol; 2001 Mar; 184(4):731-5. PubMed ID: 11262480
[TBL] [Abstract][Full Text] [Related]
12. Effect of alpha-phenyl-N-tert-butyl nitrone (PBN) on fetal cerebral energy metabolism during intrauterine ischemia and reperfusion in rats.
Nakai A; Asakura H; Taniuchi Y; Koshino T; Araki T; Siesjö BK
Pediatr Res; 2000 Apr; 47(4 Pt 1):451-6. PubMed ID: 10759150
[TBL] [Abstract][Full Text] [Related]
13. Effect of the immunosuppressant drug FK506 on neonatal cerebral mitochondrial function and energy metabolism after transient intrauterine ischemia in rats.
Shibazaki Y; Nakai A; Koshino T; Yokoyama K
Brain Res; 2001 Feb; 892(2):351-8. PubMed ID: 11172783
[TBL] [Abstract][Full Text] [Related]
14. Role and mechanisms of secondary mitochondrial failure.
Siesjö BK; Elmér E; Janelidze S; Keep M; Kristián T; Ouyang YB; Uchino H
Acta Neurochir Suppl; 1999; 73():7-13. PubMed ID: 10494335
[TBL] [Abstract][Full Text] [Related]
15. N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia.
Folbergrová J; Zhao Q; Katsura K; Siesjö BK
Proc Natl Acad Sci U S A; 1995 May; 92(11):5057-61. PubMed ID: 7761448
[TBL] [Abstract][Full Text] [Related]
16. FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release.
Shichinohe H; Kuroda S; Abumiya T; Ikeda J; Kobayashi T; Yoshimoto T; Iwasaki Y
Brain Res; 2004 Mar; 1001(1-2):51-9. PubMed ID: 14972653
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of an immunosuppressant agent on diffusion/perfusion mismatch in transient focal ischemia.
Ebisu T; Mori Y; Katsuta K; Fujikawa A; Matsuoka N; Aoki I; Umeda M; Naruse S; Tanaka C
Magn Reson Med; 2004 Jun; 51(6):1173-80. PubMed ID: 15170837
[TBL] [Abstract][Full Text] [Related]
18. Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A.
Yoshimoto T; Kristián T; Hu B; Ouyang YB; Siesjö BK
Brain Res; 2002 Apr; 932(1-2):99-109. PubMed ID: 11911866
[TBL] [Abstract][Full Text] [Related]
19. Cerebral energy state, mitochondrial function, and redox state measurements in transient ischemia.
Rehncrona S; Mela L; Chance B
Fed Proc; 1979 Oct; 38(11):2489-92. PubMed ID: 488372
[TBL] [Abstract][Full Text] [Related]
20. Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats.
Furuichi Y; Noto T; Li JY; Oku T; Ishiye M; Moriguchi A; Aramori I; Matsuoka N; Mutoh S; Yanagihara T
Brain Res; 2004 Jul; 1014(1-2):120-30. PubMed ID: 15212998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
